Clinical trial
Treatment of Major Depressive Episodes During the Course of Psychotic Disorders With Duloxetine
NCT00224302 is registered in ClinicalTrials.gov with Central Institute of Mental Health, Mannheim as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Treatment of Major Depressive Episodes During the Course of Psychotic Disorders With Duloxetine
- Lead sponsor
- Central Institute of Mental Health, Mannheim
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- August 31, 2005
- Completion date
- November 30, 2007
- Enrollment
- 20 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.